Montag A & Associates Inc. Has $8.72 Million Stock Holdings in SPDR S&P Biotech ETF $XBI

Montag A & Associates Inc. increased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 21.5% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 68,236 shares of the exchange traded fund’s stock after purchasing an additional 12,089 shares during the quarter. Montag A & Associates Inc. owned approximately 0.11% of SPDR S&P Biotech ETF worth $8,716,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in XBI. Avoro Capital Advisors LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth approximately $256,053,000. Wells Fargo & Company MN boosted its holdings in shares of SPDR S&P Biotech ETF by 75.7% in the 4th quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock worth $434,835,000 after acquiring an additional 1,536,122 shares in the last quarter. OMERS ADMINISTRATION Corp grew its position in SPDR S&P Biotech ETF by 42,425.2% during the 4th quarter. OMERS ADMINISTRATION Corp now owns 1,190,707 shares of the exchange traded fund’s stock worth $145,147,000 after acquiring an additional 1,187,907 shares during the last quarter. Morgan Stanley grew its position in SPDR S&P Biotech ETF by 8.3% during the 4th quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock worth $1,401,181,000 after acquiring an additional 882,718 shares during the last quarter. Finally, Assetmark Inc. increased its holdings in SPDR S&P Biotech ETF by 1,042,265.6% during the 4th quarter. Assetmark Inc. now owns 635,843 shares of the exchange traded fund’s stock valued at $77,528,000 after purchasing an additional 635,782 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI opened at $163.87 on Wednesday. The company has a market cap of $11.16 billion, a price-to-earnings ratio of 11.47 and a beta of 0.82. The stock has a fifty day moving average price of $138.55 and a two-hundred day moving average price of $130.59. SPDR S&P Biotech ETF has a 52-week low of $83.45 and a 52-week high of $164.35.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.